Teva Pharma (TEVA)

Company Ticker Sector | Industry Quality PAR
Teva Pharma TEVA Healthcare | Drugs (Specialty & Generic) 40 6.8%
Current Price (03/26) $15.93
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 17,851.9
Sales Growth Forecast 0.9%
Net Profit Margin 12.8%
Projected Shares Outstanding 1,030.00
EPS - Five year Forecast $2.32
Average P/E Ratio 9.5
Projected Average Price $22.13
Price Appreciation (Annualized) 6.8%
Annual Dividend Yield 0.0%
Projected Annual Return 6.8%
Quality
Financial Strength 75 18.7
EPS Stability 38 9.5
Industry Sales Growth Rate 9.5% 1.2
Industry Net Profit Margin 17.0% 9.4
Calculated Quality Rating 38.8
Fool CAPS

Total Players

2299 Outperforms
79 Underperforms
 

All-Stars (355)

346 Outperforms (97%)
9 Underperforms
 
Fundamental Data Updated: 01/04/2019

MIPAR 8.9%  
Sweet Spot 13.9% - 18.9%  

Top In Drugs (Specialty & Generic)

Ticker Quality PAR
AGN 67 14.4%
OPK 36 18.0%
PRGO 67 8.7%
ENDP 29 16.4%
PCRX 15 18.9%

Top In Healthcare

Ticker Quality PAR
ABBV 97 16.2%
ALGN 99 15.3%
CMD 92 16.2%
JAZZ 92 15.9%
CNC 80 19.0%